Absci Share Price Today
(NASDAQ: ABSI)

Name: Absci Share Price Today (NASDAQ: ABSI) - Absci Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Absci share price is $3.36 & ₹292.22 as on 6 Mar 2025, 2.30 'hrs' IST

$3.36

▲

0.09

(2.75%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Absci share price in Dollar and Rupees. Guide to invest in Absci stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Absci, along with analyst recommendations, forecasts, and comprehensive financials.

Absci share price movements

Today's Low: $3.22
Today's High: $3.40
$3.36
4.17%
Downside
Day's Volatility :5.29%
Upside
1.18%
52 Weeks Low: $2.45
52 Weeks High: $6.72
$3.36
27.08%
Downside
52 Weeks Volatility :63.54%
Upside
50.0%

Absci (ABSI) Returns

Period	Absci Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	15.07%	3.7%	0.0%
6 Months	-18.64%	-2.8%	0.0%
1 Year	-37.31%	2.5%	0.0%
3 Years	-61.2%	12.9%	-11.6%

Absci (ABSI) Key Statistics

in dollars & INR

Previous Close	$3.27
Open	$3.28
Today's High	$3.4
Today's Low	$3.22
Market Capitalization	$375.6M
Today's Volume	$2.6M
52 Week High	$6.72
52 Week Low	$2.45
Revenue TTM	$4.2M
EBITDA	$-89.7M
Earnings Per Share (EPS)	$-0.89
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-49.11%

How to invest in Absci Stock (ABSI) from India?

It is very easy for Indian residents to invest directly in Absci from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Absci stock in both Indian Rupees (INR) and US Dollars (USD). Search for Absci or ABSI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Absci or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Absci shares which would translate to 0.259 fractional shares of Absci as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Absci, in just a few clicks!

Returns in Absci (ABSI) for Indian investors in Rupees

The Absci stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Absci investment value today

Current value as on today

₹67,635

Returns

₹32,365

(-32.36%)

Returns from Absci Stock

₹37,313 (-37.31%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Absci (ABSI)

-49%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Absci Stock from India on INDmoney has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Absci

FMR Inc
11.77%
ARK Investment Management LLC
7.20%
Redmile Group, LLC
7.19%
Fred Alger Management, LLC
5.66%
BlackRock Inc
5.60%
Vanguard Group Inc
4.16%

Analyst Recommendation on Absci

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Absci(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Absci Stock (ABSI)

What analysts predicted

Upside of 156.7%

Target:

$8.63

Current:

$3.36

Insights on Absci Stock (Ticker Symbol: ABSI)

Price Movement
In the last 7 days, ABSI stock has moved down by -16.8%
Increasing Revenue
Revenue is up for the last 4 quarters, 338.0K → 1.70M (in $), with an average increase of 39.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -21.97M → -27.39M (in $), with an average decrease of 11.7% per quarter
ABSI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 103.8%
ABSI vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 112.4%
Price to Sales
ForABSI every $1 of sales, investors are willing to pay $84.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

ABSI Absci Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$2.1M	-
Net Income	$-6.8M	-
Net Profit Margin	-330.15%	-

	FY20	Y/Y Change
Revenue	$4.8M	↑ 132.04%
Net Income	$-14.6M	↑ 114.22%
Net Profit Margin	-304.79%	↑ 25.36%

	FY21	Y/Y Change
Revenue	$4.8M	↑ 0.04%
Net Income	$-101.0M	↑ 592.98%
Net Profit Margin	-2.1K%	↓ 1806.46%

	FY22	Y/Y Change
Revenue	$5.7M	↑ 20.18%
Net Income	$-104.9M	↑ 3.91%
Net Profit Margin	-1.8K%	↑ 285.88%

	FY23	Y/Y Change
Revenue	$5.7M	↓ 0.5%
Net Income	$-110.6M	↑ 5.4%
Net Profit Margin	-1.9K%	↓ 108.28%

	Q2 FY23	Q/Q Change
Revenue	$3.4M	↑ 165.33%
Net Income	$-41.7M	↑ 78.43%
Net Profit Margin	-1.2K%	↑ 602.77%

	Q3 FY23	Q/Q Change
Revenue	$744.0K	↓ 77.9%
Net Income	$-22.0M	↓ 47.22%
Net Profit Margin	-3.0K%	↓ 1718.52%

	Q4 FY23	Q/Q Change
Revenue	$338.0K	↓ 54.57%
Net Income	$-23.5M	↑ 7.05%
Net Profit Margin	-7.0K%	↓ 4009.8%

	Q1 FY24	Q/Q Change
Revenue	$898.0K	↑ 165.68%
Net Income	$-22.0M	↓ 6.67%
Net Profit Margin	-2.4K%	↑ 4518.88%

	Q2 FY24	Q/Q Change
Revenue	$1.3M	↑ 41.43%
Net Income	$-24.8M	↑ 12.63%
Net Profit Margin	-1.9K%	↑ 498.28%

	Q3 FY24	Q/Q Change
Revenue	$1.7M	↑ 33.94%
Net Income	$-27.4M	↑ 10.7%
Net Profit Margin	-1.6K%	↑ 338.12%

	FY19	Y/Y Change
Profit	$-2.3M	-

	FY20	Y/Y Change
Profit	$-6.7M	↑ 196.22%

	FY21	Y/Y Change
Profit	$-1.9M	↓ 71.93%

	FY22	Y/Y Change
Profit	$-7.3M	↑ 289.42%

	FY23	Y/Y Change
Profit	$-41.8M	↑ 474.06%

	Q2 FY23	Q/Q Change
Profit	$-131.0K	↓ 94.14%

	Q3 FY23	Q/Q Change
Profit	$-2.8M	↑ 2013.74%

	Q4 FY23	Q/Q Change
Profit	$-3.1M	↑ 13.62%

	Q1 FY24	Q/Q Change
Profit	$-2.5M	↓ 19.96%

	Q2 FY24	Q/Q Change
Profit	$-2.1M	↓ 16.04%

	Q3 FY24	Q/Q Change
Profit	$1.7M	↓ 180.46%

	FY19	Y/Y Change
Operating Cash Flow	$-6.0M	-
Investing Cash Flow	$-1.1M	-
Financing Cash Flow	$12.7M	-

	FY20	Y/Y Change
Operating Cash Flow	$-11.0M	↑ 81.86%
Investing Cash Flow	$-2.2M	↑ 99.36%
Financing Cash Flow	$71.0M	↑ 458.58%

	FY21	Y/Y Change
Operating Cash Flow	$-60.6M	↑ 452.4%
Investing Cash Flow	$-67.4M	↑ 3003.5%
Financing Cash Flow	$336.2M	↑ 373.69%

	FY22	Y/Y Change
Operating Cash Flow	$-81.3M	↑ 34.23%
Investing Cash Flow	$-127.0M	↑ 88.46%
Financing Cash Flow	$5.2M	↓ 98.44%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-19.2M	↓ 4.4%
Investing Cash Flow	$70.2M	↓ 356.96%
Financing Cash Flow	$-1.2M	↑ 10.51%

Absci Technicals Summary

Sell

Neutral

Buy

Absci is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Absci (ABSI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Absci Corporation	-22.76%	-18.64%	-37.31%	-61.2%	-84.44%
Regeneron Pharmaceuticals, Inc.	-1.42%	-40.28%	-29.31%	11.08%	44.83%
Beone Medicines Ltd	17.63%	36.87%	64.37%	45.89%	71.3%
Vertex Pharmaceuticals Incorporated	1.94%	4.92%	19.37%	108.73%	123.83%
Alnylam Pharmaceuticals, Inc.	-8.03%	-0.89%	66.53%	52.9%	126.66%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Absci Corporation	NA	NA	NA	-0.86	-0.49	-0.27	NA	1.76
Regeneron Pharmaceuticals, Inc.	17.86	17.86	1.01	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Absci Corporation	Buy	$375.6M	-84.44%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$73.8B	44.83%	17.86	31.07%
Beone Medicines Ltd	NA	$29.1B	71.3%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.9B	123.83%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	126.66%	NA	-12.37%

About Absci

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Organization	Absci
Employees	155
CEO	Mr. Sean McClain
Industry	Services

Management People of Absci

Name	Title
Mr. Sean McClain	Founder, CEO, President & Director
Dr. Zachariah Jonasson Ph.D.	Chief Business Officer & CFO
Dr. Andreas Busch Ph.D.	Chief Innovation Officer & Member of Scientific Advisory Board
Mr. Todd Bedrick CPA	Senior VP & Chief Accounting Officer
Mr. Alexander Khan CPA	VP of Finance & Head of Investor Relations
Ms. Shelby Walker J.D.	Chief Legal Officer
Ms. Karin Wierinck	Chief People Officer
Melissa Patterson Ph.D.	Chief of Staff
Jens Plassmeier Ph.D.	Senior Vice President of Synthetic Biology R&D
Mr. Wen Sha	Chief of Staff

Important FAQs about investing in ABSI Stock from India :

What is Absci share price today?

Absci share price today stands at $3.36, Open: $3.28 ; Previous Close: $3.27 ; High: $3.40 ; Low: $3.22 ; 52 Week High: $6.72 ; 52 Week Low: $2.45.

The stock opens at $3.28, after a previous close of $3.27. The stock reached a daily high of $3.40 and a low of $3.22, with a 52-week high of $6.72 and a 52-week low of $2.45.

Can Indians buy Absci shares?

Yes, Indians can invest in the Absci (ABSI) from India.

With INDmoney, you can buy Absci at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Absci at zero transaction cost.

How can I buy Absci shares from India?

It is very easy to buy Absci from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Absci (ABSI) be purchased?

Yes, you can buy fractional shares of Absci with INDmoney app.

What are the documents required to start investing in Absci stocks?

To start investing in Absci, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.